Logo image of AHR

AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis

NYSE:AHR - New York Stock Exchange, Inc. - US3981823038 - REIT - Currency: USD

34.33  +0.35 (+1.03%)

After market: 34.33 0 (0%)

Fundamental Rating

3

AHR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of AHR have multiple concerns. AHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AHR has reported negative net income.
In the past year AHR had a positive cash flow from operations.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.84%, AHR is doing worse than 64.34% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.67%, AHR is doing worse than 63.57% of the companies in the same industry.
AHR's Return On Invested Capital of 2.66% is in line compared to the rest of the industry. AHR outperforms 48.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AHR is in line with the industry average of 3.15%.
The 3 year average ROIC (1.94%) for AHR is below the current ROIC(2.66%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.84%
ROE -1.67%
ROIC 2.66%
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

The Operating Margin of AHR (6.61%) is worse than 82.17% of its industry peers.
In the last couple of years the Operating Margin of AHR has grown nicely.
Looking at the Gross Margin, with a value of 20.13%, AHR is doing worse than 92.25% of the companies in the same industry.
In the last couple of years the Gross Margin of AHR has remained more or less at the same level.
Industry RankSector Rank
OM 6.61%
PM (TTM) N/A
GM 20.13%
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AHR is destroying value.
AHR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AHR has an improved debt to assets ratio.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.52, we must say that AHR is in the distress zone and has some risk of bankruptcy.
AHR has a better Altman-Z score (1.52) than 89.92% of its industry peers.
The Debt to FCF ratio of AHR is 71.67, which is on the high side as it means it would take AHR, 71.67 years of fcf income to pay off all of its debts.
AHR has a better Debt to FCF ratio (71.67) than 62.02% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that AHR is somewhat dependend on debt financing.
AHR has a better Debt to Equity ratio (0.75) than 72.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 71.67
Altman-Z 1.52
ROIC/WACC0.34
WACC7.78%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

AHR has a Current Ratio of 0.68. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.68, AHR is doing worse than 64.34% of the companies in the same industry.
AHR has a Quick Ratio of 0.68. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.68, AHR is not doing good in the industry: 64.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

AHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.26%, which is quite impressive.
Looking at the last year, AHR shows a quite strong growth in Revenue. The Revenue has grown by 10.93% in the last year.
Measured over the past years, AHR shows a quite strong growth in Revenue. The Revenue has been growing by 17.32% on average per year.
EPS 1Y (TTM)73.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
Revenue 1Y (TTM)10.93%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%8.22%

3.2 Future

Based on estimates for the next years, AHR will show a very strong growth in Earnings Per Share. The EPS will grow by 70.27% on average per year.
The Revenue is expected to grow by 7.88% on average over the next years.
EPS Next Y234.67%
EPS Next 2Y101.62%
EPS Next 3Y70.27%
EPS Next 5YN/A
Revenue Next Year9.25%
Revenue Next 2Y7.8%
Revenue Next 3Y7.88%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AHR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 61.58, which means the current valuation is very expensive for AHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AHR is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.76. AHR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 61.58
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AHR is valued more expensive than 89.15% of the companies in the same industry.
AHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 228.95
EV/EBITDA 22.22
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AHR's earnings are expected to grow with 70.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101.62%
EPS Next 3Y70.27%

More info and screens

1

5. Dividend

5.1 Amount

AHR has a Yearly Dividend Yield of 2.93%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 6.61, AHR's dividend is way lower than its industry peers. On top of this 80.62% of the companies listed in the same industry pay a better dividend than AHR!
AHR's Dividend Yield is a higher than the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.93%

5.2 History

AHR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of AHR are negative and hence is the payout ratio. AHR will probably not be able to sustain this dividend level.
DP-319.73%
EPS Next 2Y101.62%
EPS Next 3Y70.27%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 50M -50M 100M -100M

More info and screens

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (5/23/2025, 9:12:27 PM)

After market: 34.33 0 (0%)

34.33

+0.35 (+1.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)N/A N/A
Inst Owners98.42%
Inst Owner Change5.34%
Ins Owners0.82%
Ins Owner Change7.2%
Market Cap5.48B
Analysts83.08
Price Target34.91 (1.69%)
Short Float %4.73%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield 2.93%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-319.73%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31 2025-03-31 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-327.97%
Min EPS beat(2)-359.9%
Max EPS beat(2)-296.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.23%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)6.85%
Revenue beat(4)2
Avg Revenue beat(4)1.3%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)6.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.02%
PT rev (3m)6.53%
EPS NQ rev (1m)15.56%
EPS NQ rev (3m)-30.67%
EPS NY rev (1m)-1.37%
EPS NY rev (3m)-6.49%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.58
P/S 2.63
P/FCF 228.95
P/OCF 30.94
P/B 2.41
P/tB 2.92
EV/EBITDA 22.22
EPS(TTM)-0.14
EYN/A
EPS(NY)0.56
Fwd EY1.62%
FCF(TTM)0.15
FCFY0.44%
OCF(TTM)1.11
OCFY3.23%
SpS13.05
BVpS14.25
TBVpS11.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.84%
ROE -1.67%
ROCE 3.37%
ROIC 2.66%
ROICexc 2.71%
ROICexgc 3.04%
OM 6.61%
PM (TTM) N/A
GM 20.13%
FCFM 1.15%
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexcg growth 3Y56.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 71.67
Debt/EBITDA 5.4
Cap/Depr 84.99%
Cap/Sales 7.35%
Interest Coverage 1.18
Cash Conversion 55.73%
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 1.52
F-Score7
WACC7.78%
ROIC/WACC0.34
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
EPS Next Y234.67%
EPS Next 2Y101.62%
EPS Next 3Y70.27%
EPS Next 5YN/A
Revenue 1Y (TTM)10.93%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%8.22%
Revenue Next Year9.25%
Revenue Next 2Y7.8%
Revenue Next 3Y7.88%
Revenue Next 5YN/A
EBIT growth 1Y78.29%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year168.09%
EBIT Next 3Y45.72%
EBIT Next 5YN/A
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A